1. LRR1-mediated replisome disassembly promotes DNA replication by recycling replisome components
- Author
-
Chad Liu, Nalin Ratnayeke, Jeannine Gerhardt, Marielle S. Köberlin, Madhura Deshpande, Tobias Meyer, and Yilin Fan
- Subjects
Time Factors ,Xenopus ,Cell Cycle Proteins ,Ataxia Telangiectasia Mutated Proteins ,Biochemistry ,Article ,S Phase ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cell Line, Tumor ,Neoplasms ,Humans ,Mitosis ,030304 developmental biology ,Cell Proliferation ,0303 health sciences ,biology ,DNA replication ,DNA Helicases ,Helicase ,Cell Biology ,DNA ,Protein-Tyrosine Kinases ,biology.organism_classification ,Chromatin Assembly and Disassembly ,Ubiquitin ligase ,Cell biology ,Chromatin ,Repressor Proteins ,chemistry ,Microscopy, Fluorescence ,Checkpoint Kinase 1 ,biology.protein ,Replisome ,030217 neurology & neurosurgery ,Cell Cycle and Division ,Protein Binding - Abstract
Fan et al. show that replisome disassembly during S phase is required for efficient DNA replication by recycling essential replisome components between chromatin-bound and soluble compartments., After two converging DNA replication forks meet, active replisomes are disassembled and unloaded from chromatin. A key process in replisome disassembly is the unloading of CMG helicases (CDC45–MCM–GINS), which is initiated in Caenorhabditis elegans and Xenopus laevis by the E3 ubiquitin ligase CRL2LRR1. Here, we show that human cells lacking LRR1 fail to unload CMG helicases and accumulate increasing amounts of chromatin-bound replisome components as cells progress through S phase. Markedly, we demonstrate that the failure to disassemble replisomes reduces the rate of DNA replication increasingly throughout S phase by sequestering rate-limiting replisome components on chromatin and blocking their recycling. Continued binding of CMG helicases to chromatin during G2 phase blocks mitosis by activating an ATR-mediated G2/M checkpoint. Finally, we provide evidence that LRR1 is an essential gene for human cell division, suggesting that CRL2LRR1 enzyme activity is required for the proliferation of cancer cells and is thus a potential target for cancer therapy.
- Published
- 2021